PFIZER INC.
- Country
- πΊπΈUnited States
- Ownership
- Public
- Established
- 1849-01-01
- Employees
- 88K
- Market Cap
- $163.3B
- Website
- http://www.pfizer.com
Anti-Angiogenesis Agent AG-013736 In Patients With Metastatic Melanoma
- First Posted Date
- 2004-10-14
- Last Posted Date
- 2012-06-26
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 32
- Registration Number
- NCT00094107
- Locations
- π«π·
Pfizer Investigational Site, Paris Cedex 13, France
Study of the Anti-angiogenesis Agent AG-013736 in Patients With Metastatic Thyroid Cancer
- First Posted Date
- 2004-10-11
- Last Posted Date
- 2012-06-26
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 60
- Registration Number
- NCT00094055
- Locations
- πΊπΈ
Pfizer Investigational Site, Houston, Texas, United States
A Treatment Protocol for Patients With Gastrointestinal Stromal Tumor (GIST) Who May Derive Benefit From Treatment With SU011248
- Conditions
- First Posted Date
- 2004-10-11
- Last Posted Date
- 2012-03-09
- Lead Sponsor
- Pfizer
- Registration Number
- NCT00094029
- Locations
- π»πͺ
Pfizer Investigational Site, Caracas, Distrito Capital, Venezuela
Study Of SU011248 In Patients With Metastatic Non-Small Cell Lung Cancer
- First Posted Date
- 2004-09-27
- Last Posted Date
- 2008-10-16
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 111
- Registration Number
- NCT00092001
- Locations
- πͺπΈ
Pfizer Investigational Site, Barcelona, Spain
Safety and Efficacy of an Immune Response Modifier to Treat Inoperable Advanced Melanoma Skin Lesions
- Conditions
- First Posted Date
- 2004-09-17
- Last Posted Date
- 2008-10-27
- Lead Sponsor
- Pfizer
- Registration Number
- NCT00091689
- Locations
- πΊπΈ
Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire, United States
πΊπΈOklahoma Medical Research Foundation, Oklahoma City, Oklahoma, United States
Leflunomide in Treating Patients With Anaplastic Astrocytoma in First Relapse
- Conditions
- First Posted Date
- 2004-09-14
- Last Posted Date
- 2012-09-13
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 60
- Registration Number
- NCT00003775
- Locations
- πΊπΈ
Medical College of Wisconsin, Milwaukee, Wisconsin, United States
πΊπΈUSC/Norris Comprehensive Cancer Center, Los Angeles, California, United States
πΊπΈMount Sinai Comprehensive Cancer Center, Miami Beach, Florida, United States
CMA-676 in Treating Older Patients With Acute Myeloid Leukemia in First Relapse
- Conditions
- First Posted Date
- 2004-09-13
- Last Posted Date
- 2012-08-22
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 55
- Registration Number
- NCT00003673
- Locations
- πΊπΈ
Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, Illinois, United States
πΊπΈUniversity of Chicago Cancer Research Center, Chicago, Illinois, United States
πΊπΈNew England Medical Center Hospital, Boston, Massachusetts, United States
A Phase 2, Open-Label, Multicenter Study of the GARFT Inhibitor in Patients With Metastatic Non-Small Cell Lung Cancer
- Conditions
- First Posted Date
- 2004-09-06
- Last Posted Date
- 2012-05-10
- Lead Sponsor
- Pfizer
- Registration Number
- NCT00090701
- Locations
- πΊπΈ
Pfizer Investigational Site, New York, New York, United States
A Study Of The Safety And Efficacy Of AG-013,958 In Subjects With Subfoveal Choroidal Neovascularization Associated With Age-Related Macular Degeneration
- Conditions
- First Posted Date
- 2004-08-31
- Last Posted Date
- 2011-05-27
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 155
- Registration Number
- NCT00090532
- Locations
- π¬π§
Pfizer Investigational Site, London, United Kingdom
CMA-676 in Treating Patients With Acute Myeloid Leukemia in First Relapse
- Conditions
- First Posted Date
- 2004-08-24
- Last Posted Date
- 2012-08-22
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 55
- Registration Number
- NCT00003131
- Locations
- πΊπΈ
Sylvester Cancer Center, University of Miami, Miami, Florida, United States
πΊπΈBeckman Research Institute, City of Hope, Duarte, California, United States
πΊπΈMarlene & Stewart Greenebaum Cancer Center, University of Maryland, Baltimore, Maryland, United States